Intrinsic Value of S&P & Nasdaq Contact Us

Veracyte, Inc. VCYT NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
70/100
4/7 Pass
SharesGrow Intrinsic Value
$48.21
+40.6%
Analyst Price Target
$44.50
+29.7%

Stock Statistics — VCYT

Veracyte, Inc. (VCYT) has a market capitalization of $2.73B and trades at $34.30. The 52-week range is 22.61-50.71.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 40.8, Earnings Per Share (EPS) of $0.84, annual revenue of $517.15M.

The stock has a beta of 1.96, operates in the Healthcare sector.

Trading Data
Current Price$34.30
52-Week Range22.61-50.71
Volume484.71K
Avg Volume (30D)923.06K
Market Cap$2.73B
Beta (1Y)1.96
Company
IPO Date2013-10-30
Employees824
CEOMarc A. Stapley
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS92337F1075
CUSIP92337F107
Income (Latest Year)
Revenue$517.15M
Gross Profit$360.05M
EBITDA$89.62M
Operating Income$74.15M
Net Income$66.35M
EPS$0.84
EPS Diluted$0.82
Shares Outstanding$78.58M
Balance Sheet (Latest Year)
Total Assets$1.41B
Current Assets$488.38M
Cash & ST Investments$412.89M
Total Liabilities$96.44M
Total Debt$39.65M
Net Debt$-322.92M
Total Equity$1.31B
Debt / Equity0.03
Valuation Ratios
P/E Ratio40.8
P/S Ratio5.27
P/B Ratio2.08
EV/EBITDA (approx)30.4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message